Organogenesis Holdings Stock Price on November 14, 2024
| ORGO Stock | USD 3.90 0.06 1.52% |
Below is the normalized historical share price chart for Organogenesis Holdings extending back to January 05, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Organogenesis Holdings stands at 3.90, as last reported on the 28th of November, with the highest price reaching 4.04 and the lowest price hitting 3.89 during the day.
If you're considering investing in Organogenesis Stock, it is important to understand the factors that can impact its price. Organogenesis Holdings appears to be risky, given 3 months investment horizon. Organogenesis Holdings maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12% return per unit of risk over the last 3 months. By analyzing Organogenesis Holdings' technical indicators, you can evaluate if the expected return of 0.59% is justified by implied risk. Please evaluate Organogenesis Holdings' Coefficient Of Variation of 912.62, semi deviation of 3.23, and Risk Adjusted Performance of 0.0924 to confirm if our risk estimates are consistent with your expectations.
At this time, Organogenesis Holdings' Stock Based Compensation is very stable compared to the past year. As of the 28th of November 2024, Stock Based Compensation To Revenue is likely to grow to 0.02, while Total Stockholder Equity is likely to drop about 179.4 M. . At this time, Organogenesis Holdings' Price To Sales Ratio is very stable compared to the past year. As of the 28th of November 2024, Price Earnings Ratio is likely to grow to 113.97, while Price Book Value Ratio is likely to drop 1.83. Organogenesis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of January 2017 | 200 Day MA 2.91 | 50 Day MA 3.2051 | Beta 1.598 |
Organogenesis |
Sharpe Ratio = 0.1178
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ORGO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.99 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.59 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Organogenesis Holdings is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Organogenesis Holdings by adding it to a well-diversified portfolio.
Price Book 1.8848 | Enterprise Value Ebitda 44.4058 | Price Sales 1.1363 | Shares Float 59.8 M | Wall Street Target Price 4.7 |
Related Headline
Redhill Biopharma Headline on 14th of November 2024
GT Biopharma Reports Third Quarter 2024 Financial Results by finance.yahoo.com
r8CGyW,9LIPbL9GU QeS8ht7KUe1q2Zey8MQDuJaa1vNHk6M28GEVOZ a8LxDaD8NZVqHc FPOfrM
Organogenesis Holdings Valuation on November 14, 2024
It is possible to determine the worth of Organogenesis Holdings on a given historical date. On November 14, 2024 Organogenesis was worth 4.29 at the beginning of the trading date compared to the closed value of 4.01. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Organogenesis Holdings stock. Still, in general, we apply an absolute valuation method to find Organogenesis Holdings' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Organogenesis Holdings where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Organogenesis Holdings' related companies.
| Open | High | Low | Close | Volume | |
| 3.85 | 4.57 | 3.73 | 4.43 | 2,498,191 | |
11/14/2024 | 4.29 | 4.35 | 3.63 | 4.01 | 1,785,437 |
| 4.11 | 4.12 | 3.77 | 3.86 | 687,109 |
| Backtest Organogenesis Holdings | | | Organogenesis Holdings History | | | Organogenesis Holdings Valuation | Previous | Next |
Organogenesis Holdings Trading Date Momentum on November 14, 2024
| On November 15 2024 Organogenesis Holdings was traded for 3.86 at the closing time. The top price for the day was 4.12 and the lowest listed price was 3.77 . The trading volume for the day was 687.1 K. The trading history from November 15, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.74% . The trading delta at closing time against the current closing price is 2.00% . |
Organogenesis Holdings Fundamentals Correlations and Trends
By evaluating Organogenesis Holdings' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Organogenesis Holdings' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Organogenesis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Organogenesis Holdings Stock history
Organogenesis Holdings investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Organogenesis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Organogenesis Holdings will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Organogenesis Holdings stock prices may prove useful in developing a viable investing in Organogenesis Holdings
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 132.7 M | 105.4 M | |
| Net Income Applicable To Common Shares | 17.9 M | 18.8 M |
Organogenesis Holdings Quarterly Net Working Capital |
|
Organogenesis Holdings Stock Technical Analysis
Organogenesis Holdings technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Organogenesis Holdings Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Organogenesis Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Organogenesis Holdings November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Organogenesis Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Organogenesis Holdings shares will generate the highest return on investment. By undertsting and applying Organogenesis Holdings stock market strength indicators, traders can identify Organogenesis Holdings entry and exit signals to maximize returns
Organogenesis Holdings Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Organogenesis Holdings' price direction in advance. Along with the technical and fundamental analysis of Organogenesis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Organogenesis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0924 | |||
| Jensen Alpha | 0.2438 | |||
| Total Risk Alpha | (0.21) | |||
| Sortino Ratio | 0.1152 | |||
| Treynor Ratio | 0.2139 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organogenesis Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.5 | Earnings Share (0.05) | Revenue Per Share 3.446 | Quarterly Revenue Growth 0.061 | Return On Assets 0.0164 |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.